beta-acetyldigoxin and Coronary-Disease

beta-acetyldigoxin has been researched along with Coronary-Disease* in 5 studies

Trials

1 trial(s) available for beta-acetyldigoxin and Coronary-Disease

ArticleYear
Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.
    Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:1

    Composite preparation refracterin administered in a dose of 300 mg/day for 3 days in addition to routine therapy significantly improved the results of treatment of severe cardiac insufficiency of ischemic genesis compared to placebo. Improvement of clinical status of patients is determined by positive dynamics of systolic and diastolic functions of the left ventricle.

    Topics: Acetyldigoxins; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Systole; Treatment Outcome; Ventricular Function, Left

2004

Other Studies

4 other study(ies) available for beta-acetyldigoxin and Coronary-Disease

ArticleYear
Protection from digoxin-induced coronary vasoconstriction in patients with coronary artery disease by calcium antagonists.
    The American journal of cardiology, 1999, Feb-01, Volume: 83, Issue:3

    Intravenous digoxin induces constriction of normal and stenotic coronary arteries in patients with coronary artery disease, which may lead to ischemic complications. We found that pretreatment with oral nisoldipine and intracoronary nitroglycerin neutralizes this digoxin-induced effect.

    Topics: Acetyldigoxins; Calcium Channel Blockers; Cardiotonic Agents; Coronary Angiography; Coronary Disease; Coronary Vasospasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nisoldipine; Nitroglycerin; Treatment Outcome; Vasoconstriction; Vasodilator Agents

1999
[Therapy with cardiac glycosides. Report of clinical experiences with a beta-acetyldigoxin preparation].
    Die Medizinische Welt, 1980, Volume: 31, Issue:46

    Topics: Acetyldigoxins; Adult; Aged; Coronary Disease; Digoxin; Female; Heart Failure; Humans; Male; Middle Aged

1980
[Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1979, Jan-19, Volume: 104, Issue:3

    The activity of the beta-receptor blocker pindolol (0.4 mg i.v.) was investigated alone and in combination with digitalis (moderately fast loading) in 12 patients with coronary heart disease and without manifest signs of cardiac insufficiency. These patients showed pathological increase of left ventricular filling pressure during exercise testing. The exercise-induced rise of the mean pulmonary arterial and capillary pressures were increased by pindolol. Concurrently the increase of cardiac frequency was clearly diminished during ergometry (from 107/min without pindolol to 96/min, P less than 0.005). Digoxin given orally for an average of 5 days prevented the pressure increase in the pulmonary circulation induced by pindolol during exercise testing and at rest. The frequency reducing effect of pindolol was potentiated by digitalis. Use of digitalis alone did not influence mean exercise-induced pressure increase of the pulmonary circulation. In fact in some cases deterioration of these parameters was observed.

    Topics: Acetyldigoxins; Aged; Blood Pressure; Capillaries; Coronary Disease; Digoxin; Drug Interactions; Female; Humans; Lung; Male; Middle Aged; Pindolol; Pulmonary Artery

1979
[Glycoside and coronary therapy with Ildamen-Novodigal].
    Therapie der Gegenwart, 1974, Volume: 113, Issue:11

    Topics: Acetyldigoxins; Adult; Aged; Blood Pressure; Coronary Disease; Digoxin; Drug Combinations; Female; Heart Rate; Humans; Male; Middle Aged; Oxyfedrine; Propiophenones; Time Factors

1974